Innovative Diagnostics SAS, headquartered in France, is a leading player in the diagnostics industry, specialising in advanced medical testing solutions. Founded in 2010, the company has rapidly established itself as a pioneer in the development of innovative diagnostic tools, particularly in the fields of infectious diseases and chronic conditions. With a strong operational presence across Europe and beyond, Innovative Diagnostics offers a range of unique products, including rapid test kits and laboratory diagnostics that leverage cutting-edge technology. Their commitment to accuracy and efficiency has positioned them as a trusted partner for healthcare providers. Notable achievements include several industry awards recognising their contributions to medical diagnostics, underscoring their market position as a forward-thinking entity dedicated to improving patient outcomes through reliable and accessible testing solutions.
How does Innovative Diagnostics SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Innovative Diagnostics SAS's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Innovative Diagnostics SAS, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Innovative Diagnostics SAS may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. In the context of the industry, many companies are increasingly adopting science-based targets and committing to significant reductions in greenhouse gas emissions. However, without specific initiatives or targets from Innovative Diagnostics SAS, it remains unclear how the company plans to address its carbon footprint or contribute to broader climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Innovative Diagnostics SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
